685 related articles for article (PubMed ID: 19057528)
1. Relationship of serum gamma-glutamyltransferase to atherogenic dyslipidemia and glycemic control in type 2 diabetes.
Zoppini G; Targher G; Trombetta M; Lippi G; Muggeo M
Obesity (Silver Spring); 2009 Feb; 17(2):370-4. PubMed ID: 19057528
[TBL] [Abstract][Full Text] [Related]
2. Dietary fibers and glycemic load, obesity, and plasma adiponectin levels in women with type 2 diabetes.
Qi L; Meigs JB; Liu S; Manson JE; Mantzoros C; Hu FB
Diabetes Care; 2006 Jul; 29(7):1501-5. PubMed ID: 16801569
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
[TBL] [Abstract][Full Text] [Related]
4. Serum γ-glutamyltransferase: independent predictor of risk of diabetes, hypertension, metabolic syndrome, and coronary disease.
Onat A; Can G; Örnek E; Çiçek G; Ayhan E; Doğan Y
Obesity (Silver Spring); 2012 Apr; 20(4):842-8. PubMed ID: 21633402
[TBL] [Abstract][Full Text] [Related]
5. Association of serum gamma-glutamyltransferase and alanine aminotransferase activities with risk of type 2 diabetes mellitus independent of fatty liver.
Kim CH; Park JY; Lee KU; Kim JH; Kim HK
Diabetes Metab Res Rev; 2009 Jan; 25(1):64-9. PubMed ID: 19065605
[TBL] [Abstract][Full Text] [Related]
6. Relationship between gamma-glutamyltransferase, lipids and lipoprotein(a) in the general population.
Lippi G; Targher G; Montagnana M; Salvagno GL; Guidi GC
Clin Chim Acta; 2007 Sep; 384(1-2):163-6. PubMed ID: 17601521
[TBL] [Abstract][Full Text] [Related]
7. The association of plasma cysteine and gamma-glutamyltransferase with BMI and obesity.
Elshorbagy AK; Refsum H; Smith AD; Graham IM
Obesity (Silver Spring); 2009 Jul; 17(7):1435-40. PubMed ID: 19214177
[TBL] [Abstract][Full Text] [Related]
8. Risk factors, knowledge and health status in diabetic patients.
Habib SS; Aslam M
Saudi Med J; 2003 Nov; 24(11):1219-24. PubMed ID: 14647557
[TBL] [Abstract][Full Text] [Related]
9. [The association between serum GGT level within normal range and risk factors of cardiovascular diseases].
Lim JS; Kim YJ; Chun BY; Yang JH; Lee DH; Kam S
J Prev Med Public Health; 2005 Feb; 38(1):101-6. PubMed ID: 16312915
[TBL] [Abstract][Full Text] [Related]
10. Association of gamma-glutamyltransferase with incidence of type 2 diabetes in Japan.
Fujita M; Ueno K; Hata A
Exp Biol Med (Maywood); 2010 Mar; 235(3):335-41. PubMed ID: 20404051
[TBL] [Abstract][Full Text] [Related]
11. Serum gamma-glutamyltransferase is associated with arterial stiffness in healthy individuals.
Jung CH; Yu JH; Bae SJ; Koh EH; Kim MS; Park JY; Kim HK; Lee WJ
Clin Endocrinol (Oxf); 2011 Sep; 75(3):328-34. PubMed ID: 21521327
[TBL] [Abstract][Full Text] [Related]
12. The effect of glycemic control in type 2 diabetic patients with diabetes-related dyslipidemia.
Abdel-Gayoum AG
Saudi Med J; 2004 Feb; 25(2):207-11. PubMed ID: 14968220
[TBL] [Abstract][Full Text] [Related]
13. Serum gamma-glutamyltransferase and risk of type 2 diabetes mellitus in men and women from the general population.
Meisinger C; Löwel H; Heier M; Schneider A; Thorand B;
J Intern Med; 2005 Dec; 258(6):527-35. PubMed ID: 16313476
[TBL] [Abstract][Full Text] [Related]
14. Serum gamma-glutamyl transferase within its normal concentration range is related to the presence of impaired fasting glucose and diabetes among Japanese community-dwelling persons.
Kawamoto R; Tabara Y; Kohara K; Miki T; Ohtsuka N; Kusunoki T; Takayama S; Abe M
Endocr Res; 2011; 36(2):64-73. PubMed ID: 21539445
[TBL] [Abstract][Full Text] [Related]
15. Cross-sectional association between BMI, glycemic control and energy intake in Japanese patients with type 2 diabetes. Analysis from the Japan Diabetes Complications Study.
Sone H; Yoshimura Y; Tanaka S; Iimuro S; Ohashi Y; Ito H; Seino H; Ishibashi S; Akanuma Y; Yamada N;
Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S23-9. PubMed ID: 17512082
[TBL] [Abstract][Full Text] [Related]
16. Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation.
Onat A; Can G; Hergenç G; Yazici M; Karabulut A; Albayrak S
Int J Obes (Lond); 2007 Jul; 31(7):1119-25. PubMed ID: 17299378
[TBL] [Abstract][Full Text] [Related]
17. Levels of C3 in patients with severe, morbid and extreme obesity: its relationship to insulin resistance and different cardiovascular risk factors.
Hernández-Mijares A; Jarabo-Bueno MM; López-Ruiz A; Solá-Izquierdo E; Morillas-Ariño C; Martínez-Triguero ML
Int J Obes (Lond); 2007 Jun; 31(6):927-32. PubMed ID: 17264851
[TBL] [Abstract][Full Text] [Related]
18. Effects of body mass index, plasma glucose and cholesterol levels on isolated systolic hypertension.
Ko GT; Cockram CS; Chow CC; Chan WB; So WY; Ma R; Osaki R; Chan JC
Int J Cardiol; 2005 Jun; 101(3):429-33. PubMed ID: 15907411
[TBL] [Abstract][Full Text] [Related]
19. gamma-Glutamyltransferase, obesity, physical activity, and the metabolic syndrome in indigenous Australian adults.
Li M; Campbell S; McDermott R
Obesity (Silver Spring); 2009 Apr; 17(4):809-13. PubMed ID: 19148121
[TBL] [Abstract][Full Text] [Related]
20. Serum gamma-glutamyltransferase within its normal concentration range is related to the presence of diabetes and cardiovascular risk factors.
Kim DJ; Noh JH; Cho NH; Lee BW; Choi YH; Jung JH; Min YK; Lee MS; Lee MK; Kim KW
Diabet Med; 2005 Sep; 22(9):1134-40. PubMed ID: 16108838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
